Bo-Yang Shang
Impact in
-
- Peptidase Inhibition and Analysis
-
- RNA Interference and Gene Delivery
- Cancer therapeutics and mechanisms
- Advanced biosensing and bioanalysis techniques
- Angiogenesis and VEGF in Cancer
- Histone Deacetylase Inhibitors Research
- Chemical Synthesis and Analysis
Papers in
-
- Cancer therapeutics and mechanisms 7
- Chemical Synthesis and Analysis 3
- Glycosylation and Glycoproteins Research 2
- 14-3-3 protein interactions 2
- Oncology 7
- Peptidase Inhibition and Analysis 4
- Cancer Treatment and Pharmacology 2
- Co-authors
- Yong‐Su Zhen (24 shared papers)Liang Li (5 shared papers)Bing‐Yan Zhu (2 shared papers)Shenghua Zhang (4 shared papers)Rong‐Guang Shao (5 shared papers)Yajun Lin (4 shared papers)Shuying Wu (3 shared papers)Yong‐Zhan Zhen (4 shared papers)
- Journals
- Anti-Cancer Drugs (3 papers)Oncotarget (2 papers)Cancer Letters (1 paper)Acta Pharmaceutica Sinica B (1 paper)Molecular Carcinogenesis (1 paper)
- Partner nations
- ChinaTürkiyeUnited States
In The Last Decade
Bo-Yang Shang
28 papers receiving 343 citations
Peers
Comparison fields: 5 of 68
- Oncology 80
- Molecular Biology 205
- Toxicology 10
- Biochemistry 17
- Cancer Research 35
Countries citing papers authored by Bo-Yang Shang
This map shows the geographic impact of Bo-Yang Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo-Yang Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo-Yang Shang more than expected).
Fields of papers citing papers by Bo-Yang Shang
This network shows the impact of papers produced by Bo-Yang Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo-Yang Shang. The network helps show where Bo-Yang Shang may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo-Yang Shang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 58 | |
| 2 | 2004 | 46 | |
| 3 | 2016 | 29 | |
| 4 | 2016 | 26 | |
| 5 | 2011 | 25 | |
| 6 | 2009 | 21 | |
| 7 | 2013 | 19 | |
| 8 | 2017 | 16 | |
| 9 | 2012 | 15 | |
| 10 | 2010 | 12 | |
| 11 | 2013 | 11 | |
| 12 | 2009 | 10 | |
| 13 | 2012 | 9 | |
| 14 | 2015 | 7 | |
| 15 | 2014 | 7 | |
| 16 | [Antitumor effects of the immunoconjugate composed of lidamycin and monoclonal antibody 3G11]. | 2003 | 7 |
| 17 | 2007 | 7 | |
| 18 | 2020 | 4 | |
| 19 | 2015 | 3 | |
| 20 | 2015 | 3 |
About Bo-Yang Shang
Bo-Yang Shang is a scholar working on Molecular Biology, Oncology, Pharmacology, Organic Chemistry and Cancer Research, having authored 28 papers that have together received 348 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Peptidase Inhibition and Analysis (4 papers), Cyclization and Aryne Chemistry (3 papers), Antimicrobial Peptides and Activities (3 papers), Chemical Synthesis and Analysis (3 papers), Glycosylation and Glycoproteins Research (2 papers), 14-3-3 protein interactions (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Oncology (80 citations), Molecular Biology (205 citations), Toxicology (10 citations), Biochemistry (17 citations) and Cancer Research (35 citations). Bo-Yang Shang has collaborated with scholars based in China, Türkiye and United States. Frequent co-authors include Yong‐Su Zhen, Liang Li, Bing‐Yan Zhu, Shenghua Zhang, Rong‐Guang Shao, Yajun Lin, Shuying Wu, Yong‐Zhan Zhen, Qingfang Miao and Yue Du. Their work appears in journals such as Anti-Cancer Drugs, Oncotarget, Cancer Letters, Acta Pharmaceutica Sinica B and Molecular Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.